Thyrotropin-releasing hormone (TRH), also called thyrotropin-releasing factor (TRF), thyroliberin or protirelin, is a tropic, tripeptidal hormone that stimulates the release of TSH (thyroid-stimulating hormone) and prolactin from the anterior pituitary. TRH has been used clinically for the treatment of spinocerebellar degeneration and disturbance of consciousness in humans.
Item Name Protirelin Acetate
Molecular Formula C16H22N6O4
CAS No. 24302-27-9
Features of Protirelin Acetate:
Purity (HPLC) 98%min.
Appearance White powder
Single Impurity (HPLC) 1.0%max
Amino Acid Composition ±10% of theoretical
Peptide Content (N%) ≥80.0%
Water Content (Karl Fischer) ≤5.0%
Acetate Content (HPIC) ≤10.0%
MS (ESI) Consistent
Mass Balance 95.0~105.0%
CAS No. 24302-27-9
Features of Protirelin Acetate:
Purity (HPLC) 98%min.
Appearance White powder
Single Impurity (HPLC) 1.0%max
Amino Acid Composition ±10% of theoretical
Peptide Content (N%) ≥80.0%
Water Content (Karl Fischer) ≤5.0%
Acetate Content (HPIC) ≤10.0%
MS (ESI) Consistent
Mass Balance 95.0~105.0%
Protirelin acetate should accumulator at a air-conditioned (2 ~ 8 ℃) & dry abode adequate from light, accumulate amalgamation abutting if not in use.
Read More: Protirelin acetate suppliers
No comments:
Post a Comment